Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
Pharmacogenomics of warfarin: comprehensive evaluation of important warfarin genomic response factors
Introduction: Warfarin is the most widely prescribed anticoagulant for the prevention and treatment of thromboembolic diseases. However, warfarin use is complicated by its narrow therapeutic range and inter-individual variability in the starting dose required to achieve a stable international normal...
Saved in:
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Thesis |
| Language: | English |
| Published: |
Department of Clinical Laboratory Sciences
2023
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
Similar Items: Pharmacogenomics of warfarin: comprehensive evaluation of important warfarin genomic response factors
- Warfarin time in therapeutic range of primary healthcare patients in the Western Cape, South Africa
- The impact of the cytochrome CYP2C9*2 and *3 polymorphisms in the South African Caucasian population on warfarin therapy protocols
- Pre-analytical variations affecting INR measurement for dose tailoring of anticoagulants.
- The role of warfarin pharmacogenomics on the time it takes to reach stable therapeutic International Normalized Ratio (INR) and on warfarin dose required to maintain stable therapeutic INR in Black African and Mixed Ancestry South Africans: a focus on CYP2C9 and VKORC1
- The role of genetic variation in VKORC1 and GGCX on warfarin response in a South African population
- Haemorrhage and Other Complications in Pregnant Women on Anticoagulation for Mechanical Heart Valves; a Prospective Observational Cohort Study